The price of Instil Bio Inc. (NASDAQ: TIL) closed at $1.67 in the last session, down -7.22% from day before closing price of $1.80. In other words, the price has decreased by -$0.1300 from its previous closing price. On the day, 663575 shares were traded. TIL stock price reached its highest trading level at $1.9300 during the session, while it also had its lowest trading level at $1.6300.
We take a closer look at TIL’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 7.50 and its Current Ratio is at 7.50. In the meantime, Its Debt-to-Equity ratio is 0.15 whereas as Long-Term Debt/Eq ratio is at 0.15.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Truist on November 01, 2022, Downgraded its rating to Hold and sets its target price to $6 from $16 previously.
On August 13, 2021, Robert W. Baird started tracking the stock assigning a Outperform rating and target price of $34.Robert W. Baird initiated its Outperform rating on August 13, 2021, with a $34 target price.
Stock Price History:
Over the past 52 weeks, TIL has reached a high of $23.22, while it has fallen to a 52-week low of $1.77. The 50-Day Moving Average of the stock is 4.1397, while the 200-Day Moving Average is calculated to be 6.7668.
According to the various share statistics, TIL traded on average about 542.13K shares per day over the past 3-months and 708.44k shares per day over the past 10 days. A total of 129.68M shares are outstanding, with a floating share count of 126.61M. Insiders hold about 2.44% of the company’s shares, while institutions hold 92.80% stake in the company. Shares short for TIL as of Oct 13, 2022 were 8.96M with a Short Ratio of 9.10M, compared to 8.81M on Sep 14, 2022. Therefore, it implies a Short% of Shares Outstanding of 6.91% and a Short% of Float of 62.89%.
The company has 5 analysts who recommend its stock at the moment. On average, analysts expect EPS of -$0.43 for the current quarter, with a high estimate of -$0.38 and a low estimate of -$0.47, while EPS last year was -$0.33. The consensus estimate for the next quarter is -$0.44, with high estimates of -$0.38 and low estimates of -$0.49.
Analysts are recommending an EPS of between -$1.56 and -$1.81 for the fiscal current year, implying an average EPS of -$1.67. EPS for the following year is -$1.99, with 5 analysts recommending between -$1.6 and -$2.28.